JACLYN FINN: Open Payments
NPI 1578209201 · HUDSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 31 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $281 |
| PFIZER INC. | 5 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $76 |
| Lilly USA, LLC | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Astellas Pharma US Inc | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Exact Sciences Corporation | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: Ozempic, ELIQUIS, XIFAXAN, TRELEGY ELLIPTA, MOUNJARO, Veozah, Wegovy, INSPIRE.
Industry payments across NY — which companies pay providers there.
